JPMORGAN CHASE & CO - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 42 filers reported holding SOLENO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$094
-94.1%
0.00%
Q1 2022$01,601
+1603.2%
0.00%
Q4 2021$094
-1.1%
0.00%
Q3 2021$0
-100.0%
95
-96.9%
0.00%
Q2 2021$3,000
-98.6%
3,020
-98.2%
0.00%
Q1 2021$209,000
-31.5%
166,072
+5.2%
0.00%
Q4 2020$305,000
+254.7%
157,806
+278.7%
0.00%
Q3 2020$86,000
+41.0%
41,671
+50.9%
0.00%
Q2 2020$61,000
+2950.0%
27,615
+2968.3%
0.00%
Q4 2017$2,0009000.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$9,500,0002.16%
Nantahala Capital Management 9,765,129$9,028,0000.28%
ORACLE INVESTMENT MANAGEMENT INC 2,132,000$1,971,0000.24%
Granite Point Capital Management, L.P. 701,838$649,0000.05%
OPPENHEIMER & CO INC 639,140$591,0000.01%
Ikarian Capital, LLC 121,694$112,0000.01%
Warberg Asset Management LLC 30,000$28,0000.01%
Levy Wealth Management Group, LLC 10,000$9,0000.01%
Ergoteles LLC 74,525$69,0000.00%
TWO SIGMA ADVISERS, LP 744,000$688,0000.00%
View complete list of SOLENO THERAPEUTICS INC shareholders